Published in Women's Health Weekly, December 9th, 2004
In earlier work, R.C. Armamento-Villareal at Barnes Jewish Hospital in St. Louis, Missouri, and colleagues showed "that estrogen metabolism is one of the determinants of bone density after menopause. Increased hydroxylation to relatively nonestrogenic metabolites 2-hydroxyestrone (2OHE(1)) and 2-methoxyestrone (2MeOE(1)) was associated with low bone mineral density (BMD), while increased hydroxylation to the potent 16u-hydroxyestrone (16alphaOHE(1)) and weakly estrogenic estriol (E-3) was associated with higher BMD."
In their current...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.